Categories Analysis, Earnings, Industrials

Earnings Preview: Strong truck demand expected to fuel Navistar’s Q4 growth

Navistar International (NAV) is scheduled to report earnings results for the fourth quarter of 2018 on Tuesday, December 18 before the market opens. Analysts expect the company to report earnings of $1.68 per share on revenue of $3.2 billion. Navistar has consistently topped earnings expectations over the past four quarters and can be expected to continue this trend.

Navistar has been gaining market share in the trucks segment and the increasing demand for trucks is likely to benefit the company this quarter. The truck manufacturer is likely to gain from its product portfolio as well as new product launches. The company’s truck segment is also expected to benefit from favorable economic and industry conditions.

However, during the fourth quarter Navistar might face challenges from higher costs which are likely to hurt margins. Despite the challenges, the overall sentiment surrounding the quarterly earnings appear to be positive.

In the third quarter of 2018, Navistar beat analysts’ expectations on earnings but missed the mark on revenues. Revenues rose 18% year-over-year to $2.6 billion, driven mainly by a 26% increase in core market volumes. Earnings grew to $1.71 per share from $0.38 per share in the year-ago period.

Earnings: Navistar reports solid growth in revenue and profits for Q3

During the third quarter, based on strong industry conditions, Navistar raised its full-year 2018 revenue guidance to a range of $10.1 billion to $10.4 billion. The industry retail deliveries of Class 6-8 trucks and buses in the US and Canada are forecast to be 390,000 to 410,000 units, with Class 8 retail deliveries of 260,000 to 280,000 units in 2018.

Navistar’s stock has dropped 39% so far this year while over the past one month, shares have fallen 14%.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top